J
James M. Martinez
Researcher at Baylor College of Medicine
Publications - 17
Citations - 1929
James M. Martinez is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: Bipolar disorder & Vagus nerve stimulation. The author has an hindex of 10, co-authored 15 publications receiving 1855 citations. Previous affiliations of James M. Martinez include United States Department of Veterans Affairs.
Papers
More filters
Journal ArticleDOI
Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
Gary S. Sachs,Andrew A. Nierenberg,Joseph R. Calabrese,Lauren B. Marangell,Stephen R. Wisniewski,Laszlo Gyulai,Edward S. Friedman,Charles L. Bowden,Mark D. Fossey,Michael J. Ostacher,Terence A. Ketter,Jayendra K. Patel,Peter Hauser,Daniel Rapport,James M. Martinez,Michael H. Allen,David J. Miklowitz,Michael W. Otto,Ellen B. Dennehy,Michael E. Thase +19 more
TL;DR: The use of adjunctive, standard antidepressant medication, as compared with the use of mood stabilizers, was not associated with increased efficacy or with increased risk of treatment-emergent affective switch.
Journal ArticleDOI
A Double-Blind, Placebo-Controlled Study of the Omega-3 Fatty Acid Docosahexaenoic Acid in the Treatment of Major Depression
Lauren B. Marangell,James M. Martinez,Holly A. Zboyan,Barbara Kertz,H. Florence Seung Kim,Lucy J. Puryear +5 more
TL;DR: This trial failed to show a significant effect of DHA monotherapy in subjects with major depression.
Journal ArticleDOI
Two-Year Outcome of Vagus Nerve Stimulation (VNS) for Treatment of Major Depressive Episodes
Ziad Nahas,Lauren B. Marangell,Mustafa M. Husain,A. John Rush,Harold A. Sackeim,Sarah H. Lisanby,James M. Martinez,Mark S. George +7 more
TL;DR: It is suggested that patients with chronic or recurrent, treatment-resistant depression may show long-term benefit when treated with VNS, and longer-term VNS was generally well tolerated.
Journal ArticleDOI
Prospective predictors of suicide and suicide attempts in 1,556 patients with bipolar disorders followed for up to 2 years
Lauren B. Marangell,Mark S. Bauer,Ellen B. Dennehy,Stephen R. Wisniewski,Michael H. Allen,David J. Miklowitz,Maria A. Oquendo,Ellen Frank,Roy H. Perlis,James M. Martinez,Andrea Fagiolini,Michael Otto,Cheryl A. Chessick,Holly A. Zboyan,Sachiko Miyahara,Gary S. Sachs,Michael E. Thase +16 more
TL;DR: It is indicated that patients with bipolar disorder who present with a history of SAs are over four times as likely to have a subsequent SA or completion in this high-risk cohort.
Journal ArticleDOI
Omega-3 fatty acids for the prevention of postpartum depression: negative data from a preliminary, open-label pilot study.
TL;DR: This preliminary, small, open‐label pilot study failed to show promising results for the use of omega‐3 fatty acid monotherapy beginning at 34 to 36 weeks gestation for the prevention of postpartum depression in patients with a prior post partum depression history.